Skip to main content
. 2018 May 25;26(3):439–448. doi: 10.1016/j.sjbs.2018.05.026

Fig. 5.

Fig. 5

The visualization of molecular docking analysis of wild type and mutant forms of EGFR molecule against CUCM-36, native CUCM compound and Gefitinib drugs.